Lechpammer, M.; Rao, R.; Shah, S.; Mirheydari, M.; Bhattacharya, D.; Koehler, A.; Toukam, D.K.; Haworth, K.J.; Pomeranz Krummel, D.; Sengupta, S.
Advances in Immunotherapy for the Treatment of Adult Glioblastoma: Overcoming Chemical and Physical Barriers. Cancers 2022, 14, 1627.
https://doi.org/10.3390/cancers14071627
AMA Style
Lechpammer M, Rao R, Shah S, Mirheydari M, Bhattacharya D, Koehler A, Toukam DK, Haworth KJ, Pomeranz Krummel D, Sengupta S.
Advances in Immunotherapy for the Treatment of Adult Glioblastoma: Overcoming Chemical and Physical Barriers. Cancers. 2022; 14(7):1627.
https://doi.org/10.3390/cancers14071627
Chicago/Turabian Style
Lechpammer, Mirna, Rohan Rao, Sanjit Shah, Mona Mirheydari, Debanjan Bhattacharya, Abigail Koehler, Donatien Kamdem Toukam, Kevin J. Haworth, Daniel Pomeranz Krummel, and Soma Sengupta.
2022. "Advances in Immunotherapy for the Treatment of Adult Glioblastoma: Overcoming Chemical and Physical Barriers" Cancers 14, no. 7: 1627.
https://doi.org/10.3390/cancers14071627
APA Style
Lechpammer, M., Rao, R., Shah, S., Mirheydari, M., Bhattacharya, D., Koehler, A., Toukam, D. K., Haworth, K. J., Pomeranz Krummel, D., & Sengupta, S.
(2022). Advances in Immunotherapy for the Treatment of Adult Glioblastoma: Overcoming Chemical and Physical Barriers. Cancers, 14(7), 1627.
https://doi.org/10.3390/cancers14071627
